Opsynvi (macitentan/tadalafil)

Manufacturer:
Johnson & Johnson
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
  • Manufacturer Website
phone: 
866-228-3546
Enrollment Forms:
Patient Support Form

Approved Indication:

treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adult patients of WHO functional class (FC) II-III

Conditions:

  • Pulmonary Arterial Hypertension